Prolonged QT criteria define the electrocardiographic thresholds used to identify a lengthened repolarization phase that can precede dangerous arrhythmias. Accurate recognition of these criteria helps clinicians balance life-saving therapies against proarrhythmic risk.
This article outlines the key parameters, clinical implications, and practical considerations for applying prolonged QT criteria in real-world settings, supported by data, examples, and actionable guidance.
| Parameter | Normal Range | Prolonged Threshold | Clinical Relevance |
|---|---|---|---|
| QT Interval | <440 ms (men), <460 ms (women) | >470 ms (men), >480 ms (women) | Risk of Tdp and sudden cardiac death |
| Corrected QT (QTc) | 380–450 ms (men), 380–460 ms (women) | >470 ms (men), >480 ms (women) | Rate-independent assessment of repolarization |
| QT Dispersion | <50–60 ms | >60–80 ms | Marker of regional repolarization heterogeneity |
| T Peak–T End Interval | <70 ms | >70–90 ms | Adjunct index for microvolt T-wave alternans |
Electrophysiologic Foundations of Prolonged QT
Action‑Potential Repolarization Phases
The QT interval reflects ventricular depolarization through repolarization across the myocardium. Prolonged repolarization may stem from altered potassium, sodium, or calcium currents, as well as structural or metabolic factors. Consistent application of prolonged QT criteria requires understanding the underlying phases that contribute to interval duration.
Rate‑Corrected Metrics and Variability
Heart rate impacts raw QT, so rate correction using Bazett, Fridericia, or other formulas is routine. Even with correction, QTc thresholds may vary by drug, comorbidities, or assay characteristics, so clinicians interpret values within context rather than relying on a single cutoff.
Measurement Techniques and Pitfalls
Lead Selection and Averaging
Choosing leads with the most prominent T wave, such as V2 or V5, optimizes detection of subtle prolongation. Averaging multiple beats reduces premature beats and respiratory artifacts that can inflate measurements and mislead classification.
Automatic Versus Manual Review
Algorithms in modern machines can underestimate or overshoot true intervals, particularly at baseline noise or during rapid rate changes. Manual confirmation with caliper measurement across the tangent from the nadir of the QRS to the intersection of the T wave with baseline improves accuracy in line with prolonged QT criteria.
Clinical Triggers and Causative Agents
Medication‑Induced Prolongation
Class Ia and III antiarrhythmics, certain antibiotics, antipsychotics, and antiemetics frequently prolong repolarization. Applying predefined prolonged QT criteria helps identify high-risk regimens and guides dose adjustment, interval spacing, or alternative selection.
Metabolic and Structural Contributors
Hypokalemia, hypomagnesemia, bradycardia, and structural heart disease may exacerbate repolarization delays. Assessing electrolyte balance, comorbidities, and concurrent risk factors is essential when evaluating QTc values that meet or exceed prolonged thresholds.
Risk Stratification and Monitoring Workflows
Preemptive Risk Assessment
Baseline ECG followed by serial measurements after drug initiation or dose changes supports early detection of trends. Institutions define monitoring frequency using validated pathways that integrate prolonged QT criteria with patient-level risk modifiers.
Decision Support and Escalation
Electronic alerts, combined with pharmacist or cardiology review, reduce inappropriate triggering while ensuring timely intervention when values approach or exceed established safety limits. Documenting trend analysis and clinical rationale supports coordinated management across teams.
Key Takeaways for Applying Prolonged QT Criteria
- Use consistent measurement sites and manual verification to reduce error.
- Apply rate correction appropriately and consider alternative formulas at extremes of heart rate.
- Interpret values alongside electrolytes, comorbidities, and concurrent medications.
- Leverage structured monitoring pathways and decision support for safer drug use.
- Engage cardiology or pharmacology expertise when results are borderline or clinically ambiguous.
FAQ
Reader questions
How do I choose the best lead when measuring QT interval in daily practice?
Select the lead with the tallest, most symmetrical T wave, usually V2 or V5, and confirm with a baseline tracing to minimize lead‑to‑lead variability and improve reliability of prolonged QT criteria.
Should I rely on Bazett or Fridericia correction for patients with very high or very low heart rates?
Fridericia correction performs better at extreme heart rates; however, clinical context and institutional standards guide choice, and manual measurement remains essential when rates fluctuate rapidly.
What ECG features suggest that T-wave measurement may be unreliable despite meeting prolonged QT criteria?
Low-amplitude T waves, notched or merging T–U waves, and prominent U waves can obscure true repolarization, prompting expert review and alternative metrics such as T peak–T end interval.
When should cardiology be consulted for borderline prolonged QTc values in an inpatient setting?
Consult when values approach institutional thresholds, multiple interacting risk factors exist, or there is discordance between ECG morphology and clinical stability, to align management with nuanced, patient-specific risk.